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Highlights 
 Systematic review and meta-analysis of preoperative corticosteroids in surgery for GI 
cancers 
 Reports significant association between preoperative corticosteroids and lower 
postoperative IL-6 and CRP  
 The relationship between corticosteroids and lower postoperative systemic 
inflammatory response may underpin the impact on postoperative complications 
 
Abstract 
 
Background: 
This meta-analysis examined the impact of preoperative corticosteroids on interleukin 6 (IL-
6), C-reactive protein (CRP), and complications following surgery for gastrointestinal cancer. 
 
Methods: 
A systematic review was performed using appropriate keywords.  Random-effects meta-
analysis was performed.  
 
Results: 
11 RCTs with 474 patients, were included.  Corticosteroids were significantly associated with 
lower IL-6 on postoperative day 1 (mean difference -148 pg/mL, 95% CI -205 to -92, p<0.001), 
2 (-33 pg/mL, 95% CI -58 to -8, p=0.01), and 3 (-31 pg/mL, 95% CI -52 to -11, p=0.002), 
lower CRP on day 3 (-45 mg/L, 95% CI -68 to -21, p<0.001), and 7 (-14 mg/L, 95% CI -27 to 
-1, p=0.04), and fewer postoperative infective complications (OR 0.47, 95% CI 0.26 to 0.83, 
p=0.01).  
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Conclusion: 
Corticosteroids were associated with reduction in the postoperative systemic inflammatory 
response and complications following surgery for gastrointestinal cancer.  
 
Keywords: gastrointestinal cancer, corticosteroids, postoperative complications, morbidity, 
stress response 
 
1. Introduction 
Surgery leads to a predictable metabolic, neuroendocrine and immunological response [1-2].  
Activation of the sympathetic nervous system leads to the release of catecholamines which 
induce tachycardia, hypertension and tachypnoea [3].  The cellular response to surgical trauma 
involves the production of pro-inflammatory cytokines including tumour necrosis factor (TNF) 
alpha, interleukin (IL) 1, IL-6, and IL-8 [4-5].   Such cytokines act to mobilise the innate 
immune system, resulting in the activation of neutrophils, macrophages and platelets, causing 
fever and contributing to nausea.  Circulating pro-inflammatory cytokines also act on 
hepatocytes, altering the synthesis of the acute phase proteins, such as C-reactive protein 
(CRP), albumin, fibrinogen and constituents of the complement cascade [6].   
Postoperative IL-6 and CRP concentrations in particular, have been found to be useful 
markers of the magnitude of the surgical injury [7]. The magnitude of this postoperative 
systemic inflammatory response, and in particular the routinely available CRP, is associated 
with the development of complications following colorectal surgery, oesophagectomy and liver 
resection [8-10].  Furthermore, threshold concentrations of CRP have been established, in the 
postoperative period, (190 mg/L on postoperative day 2, 170mg/L on postoperative day 3 and 
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145 mg/L on postoperative day 4), which predict the likelihood of developing or not developing 
infective complications and anastomotic leak [11-12].   
The magnitude of this postoperative systemic inflammatory response and its 
relationship with postoperative complications is of particular interest in the context of surgery 
for gastrointestinal cancers.  Previous studies have demonstrated an association between 
postoperative complications, particularly infective complications, and poorer long-term and 
oncologic outcomes following surgery for gastrointestinal cancer [13-14].  Indeed, it has been 
suggested that the magnitude of the postoperative systemic inflammatory response should 
prompt further investigation to exclude the development of a postoperative infective 
complication [15].  Furthermore, the upcoming PRECious trial (NCT02102217) aims to 
randomize patients to early CT imaging or standard postoperative care if CRP rises above 
140mg/L on postoperative day 3 to 5 following abdominal surgery [16].   
Given the relationship between the magnitude of the postoperative systemic 
inflammatory response, the development of postoperative complications, and long-term 
outcomes, there is increasing interest in the attenuation of this postoperative stress response.  
Preoperative corticosteroids are a logical choice of intervention given their potential potency 
and duration of effect [17-18].  Indeed, preoperative corticosteroids have been used as they 
have been found to reduce postoperative nausea and vomiting and analgesic requirements 
following abdominal surgery [19-20].  A recent meta-analysis reported that preoperative 
corticosteroids significantly reduced postoperative day one IL-6, postoperative complications, 
infective complications, and length of stay following abdominal surgery [21].  Preoperative 
corticosteroids have also been reported to reduce postoperative IL-6 and complication rates 
following liver resection and oesophagectomy in meta-analyses of small numbers of studies 
[22-24].  To our knowledge, no prior meta-analysis has investigated comprehensively the 
impact of preoperative corticosteroids on the postoperative surgical stress response following 
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surgery for gastrointestinal cancer.  The present meta-analysis is the first to examine their 
impact on CRP.  Both IL-6 and CRP are objective measures of the magnitude of the systemic 
inflammatory response to surgery, however CRP is more readily available in the clinical setting 
[7].  Furthermore, no meta-analysis has attempted to assess the dose response between 
preoperative corticosteroids and the magnitude of the postoperative systemic inflammatory 
response and postoperative complication rate. 
Therefore the objective of the present systematic review and meta-analysis was to 
examine the impact of preoperative corticosteroids compared to placebo in the context of 
randomized controlled trials, on the surgical stress response, in particular postoperative IL 6 
and CRP, and their relationship with the development of infective complications, following 
surgery for gastrointestinal cancers.  
 
2. Methods 
The present systematic review and meta-analysis was performed and reported in accordance 
with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
statement (Supplementary Digital Content 1 – PRISMA Checklist.docx) [25].  
 
2.1 Outcomes of interest: 
The primary outcome of interest was the impact of single dose preoperative 
corticosteroids on markers of the postoperative stress response following surgery for 
gastrointestinal cancer, in particular IL-6 and CRP.  Those studies reporting chronic 
preoperative corticosteroid use or dosing at other perioperative time points were excluded.  
Secondary outcomes included the impact of preoperative corticosteroids on postoperative 
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complications, infective complications, and anastomotic leak following surgery for 
gastrointestinal cancer, including pre-specified subgroup analysis based on surgical 
speciality/site.  Postoperative complications were coded as categorised by the authors of the 
included studies where possible.  Where there was doubt the authors of the present study 
categorised complications using a schemata described previously [26].  Post hoc meta-
regression of the impact of corticosteroid dose on postoperative day 1 IL-6 was performed 
following completion of the pre-specified analyses.  Study selection and data extraction was 
performed by one author (SM) and any uncertainties resolved by consensus discussion with 
the senior authors (PH, DM). 
 
2.2 Literature search and study selection: 
A systematic literature review was performed of the US National Library of Medicine 
(MEDLINE), PubMed, and the Cochrane Database of Systematic Reviews (CDSR) from 
inception to March 2015 inclusive.  Subsequent to several pilot search strategies the following 
search term was used, “(cancer OR malignan* OR tumour OR tumor OR neoplasm*) AND 
(steroid OR corticosteroid OR glucocorticoid OR methylpredniso* OR predniso* OR 
dexamethasone) AND (surgery OR operati* OR perioperati* OR preoperati*) along with the 
Cochrane Highly Sensitive Search Strategy for RCTs [26].  Abstracts were screened for 
relevance and those studies which were animal and pre-clinical, those studies not published in 
English, and review articles were excluded.  Relevant full text articles were then appraised.  
Randomized controlled trials of single dose preoperative corticosteroids in surgery for 
gastrointestinal cancer which reported on a marker of the postoperative systemic inflammatory 
response and postoperative complications were included in the review.  Reference lists of 
included studies were hand searched for further relevant studies. 
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2.3 Data extraction and meta-analysis: 
Data from included studies was extracted to tables and analysis was performed using 
Review Manager version 5.3 (RevMan 5.3, The Nordic Cochrane Centre, The Cochrane 
Collaboration, Copenhagen, Denmark).  Meta-analysis of the impact of corticosteroids on 
postoperative IL 6 and CRP was performed by calculating the mean difference and 95% 
confidence intervals (CI) using the inverse variance method and combining study outcomes 
using a random effects model.  Where data other than means and standard deviations were 
reported an attempt was made to calculate these values using published confidence intervals or 
p values as described by Hozo and colleagues or by the Cochrane Handbook for Systematic 
Reviews of Interventions [27-28].  Results of the meta-analysis of the impact of corticosteroids 
on infective complications was assessed by odds ratios and 95% CIs using the Mantel-Haenzsel 
method and combining study outcomes using a random effects model.  Peto odds ratios and 
their 95% CIs were combined using a fixed effects model to determine the impact of 
preoperative corticosteroids on anastomotic leak as there were a small number of events.  Meta-
regression, using a random effects model, was performed with respect to the impact of 
corticosteroid dose on postoperative day 1 IL-6, following conversion to hydrocortisone 
equivalents using a freely available Macro (Wilson, D. B. (Version 2005.05.23). Meta-analysis 
macros for SAS, SPSS, and Stata. Retrieved, 7th May 2015 from 
http://mason.gmu.edu/~dwilsonb/ma.html) with IBM SPSS version 22 for Windows 
(Chicago, IL, USA) [28].  Two tailed p values <0.05 were considered statistically significant.           
 
 
7 
 
2.4 Assessment of bias: 
Assessment of the risk of bias was carried out using the Cochrane Collaboration tool 
provided by Review Manager version 5.3 (RevMan 5.3, The Nordic Cochrane Centre, The 
Cochrane Collaboration, Copenhagen, Denmark).  Data was assessed for heterogeneity using 
the I2 statistic and χ2 test interpreted using the guidance from the Cochrane Handbook for 
Systematic Reviews of Interventions [27].  Assessment of potential publication bias was carried 
out by visual inspection of funnel plots.  P values ≤0.05 were considered statistically 
significant.   
 
3. Results 
 
3.1 Study selection process: 
The study selection process is summarised in Figure 1.  Using the search protocol 
described, 2,428 abstracts were identified.  At screening, 2,354 abstracts were excluded, of 
which 16 were animal or pre-clinical studies, 227 were not in the English language, 328 were 
review articles, 3 were duplicate publications and 1,780 were not relevant to the review.  Full 
text articles were reviewed of the remaining 74 studies.   
After assessment of full text articles 63 studies were excluded, of which 36 were not in 
gastrointestinal surgery patients, 6 did not include patients with malginancy, 14 did not include 
the intervention of interest or included corticosteroids at timings other than preoperatively, 3 
did not measure either postoperative IL-6 or CRP, 2 used historical controls, 1 was a duplicate 
study, and 1 a co-intervention of epidural analgesia alongside preoperative corticosteroids.  The 
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remaining 11 randomised controlled trials including 474  patients were included in the review 
(Table 1) [30-40].   
Of the included studies, 3 including 139 patients were in colorectal surgery [38-40], 4 
including 156 patients were in oesophageal surgery [30, 32, 34-35], and 4  including 179 
patients were in hepatic surgery [31, 33, 36-37].  Of the 474  included patients, 436  ( 92%) 
had surgery for gastrointestinal cancer while 38 (8%) from 6 studies had surgery for benign 
gastrointestinal disease but were included in the meta-analysis [31, 36-38, 40].  All included 
patients underwent open surgery, no studies of minimally invasive surgery suitable for 
inclusion were returned by the search strategy. 
 
3.2 Validity assessment: 
The risk of study bias is summarised using the RevMan 5.3 Risk of bias summary tool 
(Supplemental Digital Content 2 – Risk of bias summary.pdf).  Most studies were at low risk 
of bias however 3  did not report outcomes for patients who dropped out following 
randomisation [33, 36, 38], and 6  did not adequately report allocation concealment and 
blinding [30-31, 33-36]. 
 
3.3 Impact of preoperative corticosteroids on IL-6: 
Of the included studies, 10 including  422 patients reported the impact of preoperative 
corticosteroids on postoperative IL-6 following surgery for gastrointestinal cancer and were 
included in meta-anaysis (Figure 2) [30-38, 40].  Preoperative corticosteroids were 
significantly associated with lower serum concentrations of IL-6 following surgery for 
gastrointestinal cancer on postoperative day 1 (p<0.001), day 2 (p=0.01), and day 3 (p=0.002), 
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but not postoperative day 5 (p=0.11)  or day 7 (p=0.69).  There was a wide variation in 
heterogeneity between studies with the greatest on postoperative day 1 (I2=86%, p<0.001) and 
the least on postoperative day 7 (I2=6%, p=0.36). 
 
3.4 Impact of preoperative corticosteroids on C-reactive protein: 
Of the included studies, 6 including 206 patients reported the impact of preoperative 
corticosteroids on postoperative CRP following surgery for gastrointestinal cancer and were 
included in meta-anaysis (Figure 3) [31, 35, 37-40].  Preoperative corticosteroids were 
significantly associated with lower serum concentrations of CRP following surgery for 
gastrointestinal cancer on postoperative day 3 (p<0.001), and day 7 (p=0.04), but not 
postoperative day 1 (p=0.09) or day 2 (p=0.11).  There was a wide variation in heterogeneity 
between studies with the greatest on postoperative day 2 (I2=87%, p<0.001) and the least on 
postoperative day 7 (I2=0%, p=0.44). 
 
3.5 Impact of preoperative corticosteroid dose on postoperative IL-6 and CRP 
Within the 10 studies reporting postoperative day 1 IL-6, there was a wide variation in 
preoperative corticosteroid dose in the intervention arm [30-38, 40].  Following dose 
conversion to hydrocortisone equivalents (HEs) of both dexamethasone (1mg =  30 HEs) and 
methylprednisolone (1mg = 5 HEs) [29], it was found that 2 studies gave patients 240 HEs 
[37,39], 3 studies gave 2,500 HEs [31, 35, 36], 3 studies gave 3,500 HEs [30, 32, 34], and 2 
studies gave 10,500 HEs preoperatively [33, 37].  Meta-regression revealed no significant 
relationship between the corticosteroid dose as measured by HEs and effect size on 
postoperative day 1 IL-6 (B = -0.0065, 95% CI -0.029 to 0.016, p=0.569).  No further meta-
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regression of the impact of preoperative corticosteroid dose on postoperative IL-6 or CRP 
effect size was performed as the number of studies precluded meaningful analysis. 
 
3.6 Impact of preoperative corticosteroids on all postoperative complications 
Of the included studies 10, including 434 patients with 163 complications, reported the 
impact of preoperative corticosteroids on postoperative complications following surgery for 
gastrointestinal cancer and were included in meta-analysis (Figure 4) [30-34, 36-40].  
Preoperative corticosteroids were significantly associated with fewer postoperative 
complications following surgery for gastrointestinal cancer (OR 0.44, 95% CI 0.28 to 0.70, 
p<0.001) There was minimal heterogeneity between studies (I2=2%, p=0.42).  At subgroup 
analysis, preoperative corticosteroids were significantly associated with fewer postoperative 
complications following surgery for oesophageal ( p=0.01) and liver (p=0.02) but not colorectal 
malignancy (p=0.25).   
 
3.7 Impact of preoperative corticosteroids on postoperative infective complications: 
Of the included studies 9, including 388 patients with 68 infective complications, 
reported the impact of preoperative corticosteroids on postoperative infective complications 
following surgery for gastrointestinal cancer and were included in meta-analysis (Figure 5) 
[31-32, 34-40].  Preoperative corticosteroids were significantly associated with fewer 
postoperative infective complications following surgery for gastrointestinal cancer (OR 0.47, 
95% CI 0.26 to 0.83, p=0.01).  There was minimal heterogeneity between studies (I2=0%, 
p=0.54).  At subgroup analysis, preoperative corticosteroids were significantly associated with 
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fewer postoperative infective complications following surgery for liver malignancy (p=0.02) 
but not colorectal (p=0.15) or oesophageal malignancy (p=0.58).   
 
3.8 Impact of preoperative corticosteroids on anastomotic leak: 
Of the included studies 7, including 295 patients and 19 events, reported the impact of 
preoperative corticosteroids on anastomotic leak following colorectal or oesophageal surgery 
for cancer and were included in meta-analysis (Figure 6) [30, 32, 34-35, 38-40].  The remaining 
5 studies were in hepatic surgery thus did not report anastomotic leak.  There was no significant 
association between preoperative corticosteroids and anastomotic leak (OR 1.13, 95% CI 0.44 
to 2.90, p=0.79).  There was minimal heterogeneity between studies (I2=0%, p=0.61).  At 
subgroup analysis there was no association between preoperative corticosteroids and 
anastomotic leak following surgery for either colorectal (p=0.71) or oesophageal malignancy 
(p=1.00).   
 
3.9 Assessment of publication bias: 
Visual assessment of a funnel plot of studies reporting the impact of preoperative 
corticosteroids on postoperative CRP and all complications following surgery for 
gastrointestinal cancer (Figure 7) suggests that there may be evidence of publication bias with 
a positive skew amongst smaller studies. 
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4. Discussion 
The present systematic review and meta-analysis reports that preoperative corticosteroids 
reduce the magnitude of the systemic inflammatory response, in particular IL-6 and CRP, and 
are significantly associated with fewer postoperative infective complications following surgery 
for gastrointestinal cancer.   
The results of the present study with regard to postoperative IL-6 are consistent with 
recent meta-analyses of randomized controlled trials of preoperative corticosteroids in 
colorectal surgery, liver surgery and esophagectomy [21-24, 41].  In addition, the present meta-
analysis reports a significant reduction in IL-6 on postoperative days 2, 3 and 5 in those patients 
given preoperative corticosteroids.    The present study reports a significant reduction in CRP 
on postoperative days 3 and 7 in those given preoperative corticosteroids however found no 
significant impact of preoperative corticosteroids on postoperative day 1 or 2.  As CRP is 
usually seen to reach its peak concentration around 48 hours after the initial surgical insult it 
may be that comparison on postoperative day 1 and 2 does not accurately reflect the influence 
of preoperative corticosteroids on the postoperative systemic inflammatory response [6].  It is 
of interest that even within the control groups of the studies included in the present meta-
analysis, the mean data were below postoperative CRP thresholds associated with the 
development of postoperative complications.  For example, it has recently been advocated that 
simple objective postoperative CRP thresholds >150mg/l on post-operative days 3-5 be used 
to alert clinicians to the risk of post-operative complications before clinical signs and symptoms 
[42]. Moreover, when examined in detail by operative site, the mean CRP concentrations 
reported by the studies included in the present meta-analysis were significantly lower than 
values reported in a comprehensive systematic review of the timing and peak magnitude of 
postoperative IL-6 and CRP following elective colorectal, oesophageal and liver surgery [7].  
Therefore, it may be that patients recruited to previous randomised controlled trials of 
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preoperative corticosteroids had a lower systemic inflammatory response compared with 
unselected patients.  If this were to be the case then this may have implications for the 
randomised trials that reported efficacy of  pre-operative corticosteroids on complication rates.  
In particular, it may be that the efficacy was underestimated. 
 As with previous meta-analyses there was a wide variation in corticosteroid dose 
equivalence and timing [43].  The degree of heterogeneity between studies within each 
speciality in the present meta-analysis suggests that this does have an impact on the degree of 
attenuation of the postoperative systemic inflammatory response.  Within the present meta-
analysis, no significant association was found between varying corticosteroid dose 
equivalencies and postoperative day 1 IL-6 effect size between studies.  However, this analysis 
was performed on a post hoc basis in response to data heterogeneity.  In addition, dose timing 
and the differing half-life of dexamethasone and methylprednisolone were not considered and 
may be implicated [43].  The results of the present study do not define the ideal dose of 
preoperative corticosteroid to moderate the systemic inflammatory response or postoperative 
nausea and vomiting.  For example, a recent meta-analysis of preoperative corticosteroids in 
the prevention of postoperative nausea and vomiting reported similar efficacy with lower doses 
of IV dexamethasone (4-5mg), when compared to higher doses (8-10mg) [44].  However, the 
efficacy of preoperative corticosteroids will depend on a number of factors including the 
magnitude of the systemic inflammatory response (eg. preventing patients breaching 
established threshold values of CRP) and the route and frequency of dose (eg. large single dose 
or smaller multiple doses).  Further work, in the context of randomised trials examining varying 
corticosteroid doses with reference  the magnitude of the post-operative systemic inflammatory 
response, is therefore required. 
Postoperative IL-6 and CRP concentrations have been reported to be markers of the 
magnitude of the postoperative stress response [7].  In relation to short term postoperative 
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morbidity, several recent meta-analyses have demonstrated the utility of elevated postoperative 
serum CRP in the early diagnosis of infective complications and anastomotic leak in 
gastrointestinal surgery [10, 12, 15].  In addition, the magnitude of the postoperative CRP has 
been reported to be associated with complication severity following colorectal surgery  [45-
46].  Although this inflammatory response may represent an epiphenomenon rather than a 
cause of infective complications, given that the presence of a systemic inflammatory response 
(as evidenced by IL-6 or CRP) [7] is primarily an upregulated innate immune response (with  
consequent suppression of adaptive immunity), it  is plausible that the magnitude of the 
postoperative systemic inflammatory response plays a role in the development of postoperative 
infective complications [47].  Indeed, the results of the present review are consistent with such 
a causal relationship.  However, further interventional studies of preoperative corticosteroids 
would be required to prove such a relationship. 
It is known that corticosteroids alter gene transcription and thus protein synthesis 
following intracellular receptor binding, however the exact mechanism by which they act to 
reduce inflammation is poorly understood [48].  Glucocorticoids act on the innate immune 
system including myeloid tissue, inhibiting the activity of neutrophils and macrophages via 
reduced transcription of several proinflammatory cytokines, and by increasing the transcription 
of lipocortins which themselves inhibit cyclo-oxygenase dependent inflammation pathways 
[49].  They are also recognised to have a down regulatory effect on adaptive immunity and 
lymphoid tissue, probably via inhibition of nuclear factor κB (NF- κB) [50].  The results of the 
present review taken with that of previous meta-analyses suggest that, in the postoperative 
period, the action of corticosteroid may at least be partly due to reduced transcription and 
production of IL-6 by innate immune cells, consequently reduced synthesis of CRP by 
hepatocytes [21, 23-24].  Although both IL-6 and CRP are objective markers of the 
postoperative stress response and have both been associated with the development of 
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complications following gastrointestinal surgery, CRP is routinely available in clinical practice 
[7].  Indeed, in a recent review of risk factors associated with anastomotic leak following 
colorectal surgery the authors advocate routine measurement of CRP on postoperative days 3 
to 5, with a concentration greater than 150mg/L prompting the investigation of potentially 
developing complications [42].  In addition, other studies have investigated the use of other 
markers associated with the development of postoperative complications, for example 
procalcitonin, however the IMACORS study reported that CRP was more accurate in the 
detection of postoperative infective complications following colorectal surgery [51].  
Furthermore, it has long been recognised that albumin is also a marker of the postoperative 
stress response [6], and is associated with postoperative complications and mortality [52].  It 
remains to be determined whether albumin, in terms of predicting post-operative complication, 
offers prognostic value in addition to that of CRP and whether albumin may be a useful 
therapeutic target for pre-operative corticosteroids. 
 
There has long been a concern regarding the inhibitory effect of corticosteroids on 
collagen formation leading to postoperative wound dehiscence and potentially anastomotic 
leak.  However, the present meta-analysis along with prior randomised trials and meta-analyses 
have failed to demonstrate a significant increase in either complication in patients given 
corticosteroids [21, 24, 53-54].  Much of the prior evidence regarding wound healing and 
infection has arisen from literature surrounding surgery for inflammatory bowel disease, in 
those undergoing transplant surgery, or in those with diseases of the hypothalamo-pituitary-
adrenal axis [55].  Indeed, recent meta-analysis of both experimental and clinical trials suggests 
that receiving corticosteroids at standard therapeutic doses for 10 days or less is unlikely to 
impair wound healing [56].  Lastly, as recent preliminary reports suggest that preoperative 
corticosteroids may have a detrimental impact on oncologic outcome, some consideration 
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should be given to their impact on longer term outcomes, especially in surgery for 
gastrointestinal cancer [57-58]. 
The main limitation of the present systematic review and meta-analysis is the relatively 
small number of patients included.  To maximise the number of patients within the analysis 
several gastrointestinal surgical specialities were considered together using a random effects 
model.  In addition there were a small number of patients included within the present meta-
analysis who had undergone surgery for benign gastrointestinal disease.  Indeed these factors, 
to an extent, limit the generalisability of the results of the present study.  However, the 
exclusion of the 6 studies which included a small proportion of patients without malignant 
disease would have significantly reduced the power of the present meta-analysis [30, 35-37, 
39].  A significant degree of heterogeneity was reported in the analysis of postoperative IL-6 
and CRP.  This may reflect the pooling of the various surgical specialities.  However, no study 
individually reported a statistically significant increase in either postoperative IL-6 or CRP in 
the corticosteroid treatment group.  Thus, although there are likely to be differences in the 
studied patient groups or methodology, the direction of the treatment effect at least, is very 
likely to be similar across the included studies.  There was a wide variability in concentrations 
of IL 6 and CRP amongst studies within the same postoperative day.  Both the biological 
variability of IL 6 and CRP, alongside the variety of surgical specialties included in the present 
study may account for this [59].  Other potential confounders include the use of a variety of 
preoperative corticosteroids, their dose and timing, although a random effects model was used 
as an attempt to minimise this, alongside meta-regression techniques.   In addition, there may 
be a degree of publication bias toward positive results amongst the smaller studies included in 
the meta-analysis.   In the present study, despite a broad and inclusive search strategy, there 
were no trials conducted in the USA included in the analysis.  Therefore, it would appear that 
although preoperative corticosteroids are used in routine clinical practice in the USA, no formal 
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RCTs have been undertaken there.  Finally, all of those studies included in the present meta-
analysis were published prior to 2009.  A single study in liver surgery, published in 2010, was 
excluded due to the use of postoperative corticosteroids in the treatment group, however it 
interestingly reported reduced concentrations of IL-6 and CRP in the treatment group with a 
trend toward fewer complications [60].  The lack of more recent studies may relate to the rapid 
uptake of enhanced recovery or fast-track postoperative protocols in gastrointestinal surgery 
which often include preoperative corticosteroids for the prevention of postoperative nausea and 
vomiting  [61].  Nevertheless, the results of the present review with regard to the effect of 
preoperative corticosteroids on IL-6 and CRP provide important new information since they 
suggest that the efficacy of such interventions may be dependent on the magnitude of the 
postoperative systemic inflammatory response. 
The results of the present systematic review and meta-analysis suggest that preoperative 
corticosteroids are associated with a reduction in the magnitude of the postoperative stress 
response and , within some subgroups, the likelihood of postoperative complications following 
surgery for gastrointestinal cancer.  Although the magnitude of this postoperative systemic 
inflammatory response, especially CRP, has been associated with the development of 
complications following surgery, relatively few studies, have examined whether the attenuation 
of the systemic inflammatory response with preoperative corticosteroids may indeed reduce 
infective complication rates.    Clearly, given the significant heterogeneity in the small number 
of studies included in the present meta-analysis, further work is warranted. 
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8. Figures and Legends 
8.1 Figure 1:  PRISMA flowchart demonstrating study selection 
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8.2 Figure 2: Impact of preoperative corticosteroids on serum interleukin 6 following surgery 
for gastrointestinal cancer 
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8.3 Figure 3: Impact of preoperative corticosteroids on serum C-reactive protein following 
surgery for gastrointestinal cancer 
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8.4 Figure 4: Impact of preoperative corticosteroids on all postoperative complications 
following surgery for gastrointestinal cancer 
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8.5 Figure 5: Impact of preoperative corticosteroids on infective postoperative complications 
following surgery for gastrointestinal cancer 
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Total events
Heterogeneity: Tau² = 0.00; Chi² = 0.48, df = 2 (P = 0.78); I² = 0%
Test for overall effect: Z = 2.35 (P = 0.02)
Total (95% CI)
Total events
Heterogeneity: Tau² = 0.00; Chi² = 5.97, df = 7 (P = 0.54); I² = 0%
Test for overall effect: Z = 2.57 (P = 0.01)
Test for subgroup differences: Chi² = 1.61, df = 2 (P = 0.45), I² = 0%
Events
1
9
4
14
0
3
0
3
6
1
0
2
0
3
23
Total
14
29
26
69
0
33
7
20
60
17
0
36
10
63
192
Events
5
11
7
23
0
2
0
7
9
2
0
10
1
13
45
Total
13
31
26
70
0
33
10
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63
16
0
37
10
63
196
Weight
6.3%
29.4%
18.1%
53.8%
9.9%
14.5%
24.4%
5.4%
13.3%
3.1%
21.8%
100.0%
M-H, Random, 95% CI
0.12 [0.01, 1.25]
0.82 [0.28, 2.40]
0.49 [0.12, 1.95]
0.54 [0.23, 1.25]
Not estimable
1.55 [0.24, 9.94]
Not estimable
0.33 [0.07, 1.52]
0.65 [0.14, 2.95]
0.44 [0.04, 5.36]
Not estimable
0.16 [0.03, 0.79]
0.30 [0.01, 8.33]
0.22 [0.06, 0.78]
0.47 [0.26, 0.83]
Year
2008
2009
2009
1998
2002
2003
2005
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2003
2006
2007
Steroid Control Odds Ratio Odds Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours steroid Favours control
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8.6 Figure 6: Impact of preoperative corticosteroids on anastomotic leak following surgery for 
gastrointestinal cancer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study or Subgroup
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Kirdak et al. 2008
Zargar-Shoshtari et al. 2009
Vignali et al. 2009
Subtotal (95% CI)
Total events
Heterogeneity: Chi² = 2.14, df = 2 (P = 0.34); I² = 6%
Test for overall effect: Z = 0.37 (P = 0.71)
1.3.2 Oesophageal
Matsutani et al. 1998
Sato et al. 2002
Takeda et al. 2003
Yano et al. 2005
Subtotal (95% CI)
Total events
Heterogeneity: Chi² = 0.51, df = 1 (P = 0.47); I² = 0%
Test for overall effect: Z = 0.00 (P = 1.00)
Total (95% CI)
Total events
Heterogeneity: Chi² = 2.72, df = 4 (P = 0.61); I² = 0%
Test for overall effect: Z = 0.26 (P = 0.79)
Test for subgroup differences: Chi² = 0.07, df = 1 (P = 0.79), I² = 0%
Events
3
0
2
5
0
1
0
4
5
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Total
29
14
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69
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33
7
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1
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2
0
3
5
9
Total
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19
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10
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Weight
21.8%
5.7%
21.7%
49.2%
16.7%
34.1%
50.8%
100.0%
Peto, Fixed, 95% CI
3.08 [0.41, 23.06]
0.13 [0.00, 6.33]
1.00 [0.13, 7.54]
1.29 [0.34, 4.94]
Not estimable
0.50 [0.05, 5.01]
Not estimable
1.40 [0.28, 7.02]
1.00 [0.27, 3.74]
1.13 [0.44, 2.90]
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33 
 
Subgroups
Postoperative day 1 Postoperative day 2 Postoperative day 3 Postoperative day 7
-100 -50 0 50 100
0
4
8
12
16
20
MD
SE(MD)
Subgroups
Colorectal Oesophageal Hepatic
0.01 0.1 1 10 100
0
0.5
1
1.5
2
OR
SE(log[OR])
8.7 Figure 7: Funnel plots of the impact of preoperative corticosteroids on A: postoperative C-
reactive protein and B: all postoperative complications following surgery for gastrointestinal 
cancer 
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7. Tables and footnotes 
7.1 Table 1: Clinical trials investigating the impact of preoperative steroids on the postoperative stress response following surgery for 
gastrointestinal cancer 
Author Year Journal Country n Speciality Steroid/dose/route
/timing 
Surgical stress 
response  
Period Significant outcomes 
Kirdak et al. 2008 Am Surg Turkey 27 Colorectal Dexamethasone 8mg IV 
at induction 
Pain, nausea, IL 6, CRP POD 1-3 None 
Zargar-
Shoshtari et al.  
2009 Br J Surg New 
Zealand 
60 Colorectal Dexamethasone 8mg 
IV, at induction 
Pain, nausea, WCC, 
Neutrophils, CRP, IL 1β, 
IL 6, IL 8, IL 10, IL 13, 
TNFα, (serum and 
peritoneal cytokines), 
fatigue 
Pain and nausea  POD 
1-3, Fatigue POD 1-
60, CRP and cytokines 
POD 1 
Higher WCC,  neutrophils 
and lower pain, nausea, 
serum IL 6, serum IL 8, 
peritoneal IL 6, peritoneal IL 
13 in steroid group 
Vignali et al. 2009 Dis Colon 
Rectum 
Italy 52 Colorectal Methylprednisolone 
30mg/kg IV, 60 mins 
preop 
Pain, FVC, FEV1, CRP, 
IL 6, IL 8, TNFα  
POD 1-5 Higher FVC, FEV1 and 
lower pain, CRP, IL 6, IL 8 
in steroid group 
Matsutani et al. 1998 J Surg Res Japan 33 Oesophageal Methylprednisolone 
10mg/kg at induction 
TNFα, IL 6, PT, APTT, 
AT III 
POD 1-7 Higher AT III and lower 
TNFα, IL 6 in steroid group 
Sato et al. 2002 Ann Surg Japan 66 Oesophageal Methylprednisolone 
10mg/kg at induction 
IL 1, IL 6, IL 8, IL 10, 
cortisol, lymphocytes, 
neutrophils 
POD 1-7 Higher IL 10 and lower IL 1, 
IL 6, and IL 8 in steroid 
group 
Takeda et al.  2003 J Nippon 
Med Sch 
Japan 17 Oesophageal Methylprednisolone 
10mg/kg IV at induction 
Serum and 
broncheoalveolar IL 6 and 
IL 8 
POD 1 Lower serum IL 6 and IL 8, 
and lower broncheoalveolar 
IL 8 in steroid group 
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Yano et al.  2005 Hepatogas
troenterol
ogy 
Japan 40 Oesophageal Methylprednisolone 
500mg IV 2hrs preop 
IL 6, IL 8, IL 10, WCC, 
rectal pHi, body weight 
POD 1-3 Lower IL 6, IL 8 and CRP 
Yamashita et al. 2001 Arch Surg Japan 33 Liver Methylprednisolone 
500mg IV 2hrs preop 
IL 6, IL 10, CRP, Bil, 
AST, ALT 
POD 1-7 Higher IL 10 and lower Bil, 
IL 6, CRP in steroid group 
Muratore et al. 2003 Br J Surg Italy 53 Liver Methylprednisolone 
30mg/kg IV at induction 
IL 6, Bil, AST, ALT, PT POD 1 Lower IL 6 in steroid group 
Aldrighetti et al. 2006 Liver 
Transpl 
Italy 73 Liver Methylprednisolone 
500mg IV at induction 
IL 6, TNFα, Bil, AST, 
ALT, PT, platelets, AT III, 
D-dimer 
POD 1-5 Higher AT III, platelets, and 
lower IL 6, TNFα in steroid 
group 
Schmidt et al. 2007 J 
Hepatobili
ary 
Pancreat 
Surgery 
Germany 20 Liver Methylprednisolone 
30mg/kg IV 90 mins 
preop 
IL 6, IL 8, IL 10, CRP, 
TNFα, HLA-DR, Bil 
 Lower IL 6, IL 8, CRP, 
TNFα, Bil in steroid group 
POD postoperative day,  IV intravenous,  IL interleukin, CRP C-reactive protein, TNF tumour necrosis factor, WCC white cell count, FVC forced vital capacity, FEV forced 
expiratory volume, ADH anti-diuretic hormone, AT antithrombin, Bil bilirubin, AST aspartate transaminase, ALT alanine transaminase, PT prothrombin time, HLA human 
leukocyte antigen 
 
